Imperial Brands PLC (IMB) Earnings Call Transcript & Summary

May 18, 2021

London Stock Exchange GB Consumer Staples Tobacco earnings 82 min

Earnings Call Speaker Segments

Stefan Bomhard

executive
#1

Morning, everyone, and welcome — thanks for being here for our interim results presentation. With me today are Oliver Tant, our Chief Financial Officer, and Peter Durman, our Investor Relations Director. Our incoming Chief Financial Officer, Lukas Paravicini, is here as well. Lukas came to Imperial and the board on May 1st, 2021. Tomorrow he'll be formally appointed CFO, and he'll be working alongside Oliver to make sure the handover is smooth and orderly. Before we get into the results, I'll pass things to Lukas for a few brief words.

Lukas Paravicini

executive
#2

Thanks, Stefan, and good morning to all of you. It's a real pleasure to be with the team this morning and to have the chance to say a few words about myself. Maybe a bit about where I come from. My career has spanned 20 years in consumer goods, where I've held a variety of senior finance and operational positions at big international companies. My time at Nestlé covered 22 years, across many different areas of the business, both in Switzerland and across a number of Latin American markets. I was also with Fonterra for six years — the largest dairy cooperative in the world, home to some well-known leading dairy brands — where I came in initially as CFO and later took on the role of Chief Operating Officer for its global consumer and foodservice business. What I offer is a mix of solid financial and commercial know-how, along with hands-on experience running major change programs, among them rolling out global shared services within large international organizations — all of which ought to be relevant for Imperial. I'm truly glad to be coming on board at such an exciting moment, as we start putting the new strategy into action and making the changes needed to improve performance and create lasting shareholder value. I can't wait to get stuck into the business and to reach a point where we're able to meet face to face.

Lukas Paravicini

executive
#3

I’m eager to build an open, transparent relationship with every investor. Thank you. At this point, I’ll return the call to Stefan.

Stefan Bomhard

executive
#4

Thank you, Lukas. I'll begin today with a few performance highlights, and after that Oliver will walk you through the financial results in greater detail. I'll share more color on how the new strategy is being implemented and on some of the operational steps we're taking to strengthen performance. Then I'll close with our outlook and priorities for 2021, and I look forward to taking your questions afterward. I'm pleased with how far we've come in putting into practice the new strategy we announced in January. What encourages me most in these results is the progress toward stabilizing aggregate market share performance across our top five priority markets, after several years of consecutive decline. That reflects improving momentum stemming from a greater focus on collaboration and performance management with those markets, all of which forms part of the important changes made over the past year. In NGP, the steps taken over the past year to focus our investments and improve returns have delivered a further reduction in losses. This is about resetting the business and creating a sound foundation so that, over time, we can make a meaningful contribution to harm reduction. It has been a good start to the year as we begin to build momentum, with growth in net revenue, operating profit, and strong cash flow, and I want to thank all of our people for their great work in ensuring the business keeps moving forward in a COVID-19 environment.

Stefan Bomhard

executive
#5

I'm happy with how the year has begun, and we're still on course to post full-year results that match our guidance. As I mentioned before, share in our five priority markets edged up 6 basis points, versus a 37 basis points drop during the same stretch a year ago. Gains in the U.S., U.K., and Spain were partly offset by losses in Germany and Australia, where turning things around will take time. Net revenue rose 3.5%, helped by solid pricing in tobacco and improved NGP sales against a comparatively weak comparator period. The business has done well even though COVID-19 keeps shaping how consumers and customers buy. The absence of international travel has hurt our duty-free sales and has also weighed on demand in various markets. Oliver will go into more detail later. Operating profit growth of 8.1% came from a better NGP performance against the period hit by write-downs, along with a sharper focus on investment that prioritizes the markets with the strongest growth prospects. A stronger showing at Logista also added to profit growth. Tobacco revenue grew. Tobacco profitability was hit by some temporary factors that Oliver will walk you through shortly.

Stefan Bomhard

executive
#6

The positive side is that underlying tobacco profitability—when you strip out those factors—rose by nearly 5%, which shows how our strategic emphasis on generating results from our five biggest and most profitable markets is paying off. We also turned in another robust cash showing measured over 12 months, delivering net cash flow of £2.5 billion, which backs up our priorities around cutting debt. Since the new strategy was unveiled in January, my attention has been on putting it into practice and taking steps that lift performance. Getting the business to where it needs to be will take time, but I think we're making the right calls to build value for our shareholders. One crucial part of those right calls is the clear prioritization of markets that we've now established, and we're starting to shift investments so they back the strategic initiatives across our five priority markets. In NGP, we've acted to reset how we approach things, and we're running operations in a far more measured and disciplined way. I wanted to see this side of Imperial thrive so that we could contribute meaningfully to harm reduction. Our plans for market trials in heated tobacco and vapor remain on track. That means putting money into markets where we're confident we can win and pulling out of markets where we doubt we can generate shareholder value with our NGP portfolio.

Stefan Bomhard

executive
#7

Assembling the right leadership team—one equipped with the qualities needed to deliver the new strategy—has also been a major priority. That team combines fresh capabilities, skills, and expertise drawn from beyond the industry with the valuable experience we already hold in tobacco, both at the senior executive level and more broadly across the business. I'm delighted that, alongside the new strategy, we've managed to bring some exceptionally high-caliber people with blue-chip FMCG backgrounds—companies such as Nestlé, Unilever, or PepsiCo—into the tobacco industry. We're also starting to put the organizational changes in place and to adopt the new ways of working that we set out in the strategy update. Later on, I'll describe the changes already underway in our sales and marketing organization aimed at streamlining and simplifying our operations. Before I pass things to Oliver for his financial review—this being Oliver's final results presentation for Imperial—I'd like to use this moment to thank Oliver for his 7.5 Years of service to Imperial. On a personal level, I also want to thank him for the very warm welcome he gave me upon joining the group, and for the help and support he provided during my induction.

Stefan Bomhard

executive
#8

I want to wish you the very best in your retirement. Oliver, the floor is yours.

Oliver Tant

executive
#9

Thank you, Stefan, and good morning to all of you. To start, I want to express my satisfaction at being able to present stronger figures for what is my final set of financial results. I would also like to use this moment to express my gratitude to each of you for the exchanges we've shared while I've been in this role, and to mention how greatly I've valued collaborating with Stefan and the renewed executive team throughout the past year; I wish both them and Imperial every success going forward. As Stefan mentioned before, our business is doing well, delivering growth in revenue and profit — though this comes against a weaker comparator period — along with continued strong cash delivery. Total tobacco volumes fell 3.3%, which includes a 1.3% reduction attributable to our global duty-free business, since restrictions have kept affecting travel. A decrease in U.S. inventory added a 0.8% decline, following strong wholesaler purchases in March last year. Once these effects are excluded, underlying volumes were down 1.2%, which is better than the level we've grown accustomed to in recent years. Our volume performance got a boost from a 30 basis point share gain across our footprint, along with improved market size performances, especially in Northern Europe. Let's examine more closely how COVID-19 has kept influencing market size.

Oliver Tant

executive
#10

In Spain, the Canaries, and the duty-free channel, for instance, we kept feeling the effects of closed borders and less travel. By contrast, markets in Northern Europe gained from stronger domestic sales and lower illicit trade levels. The pace at which the U.S. market shrank has also eased from its recent historic trend, with consumer spending lifted by stimulus payments. The COVID-19 effect on market size will probably be less pronounced in the second half, as we lap a comparator already hit by the pandemic. All in all, net revenue rose 3.5% at constant currency. Even with the U.S. wholesaler inventory movements and the drop in duty-free sales, we lifted tobacco net revenue by 3.2%. Tobacco price mix came in at 6.5%, helped by strong pricing and by a return to growth in our U.S. mass-market cigar business, which aided product mix. Geography mix was neutral. Our NGP revenues are up 16% against a weak comparator, one that was affected by supply chain destocking. On tobacco price mix in more detail, pricing has stayed strong in both Europe and the U.S. In Europe, positive market mix from sales growth in the higher margin European markets of the U.K., Germany, and the Nordics helped tobacco price mix.

Oliver Tant

executive
#11

When it comes to total net revenue, though, our results were constrained by lower volumes in Southern European markets and weaker sales in the duty-free channel, both of which sit within Europe. In the U.S., price mix rose 12.7%, lifted by two cigarette price hikes during the first half and by carryover from last year's pricing. Price mix also got a boost from an exceptionally strong showing in our mass-market cigar business. In AAA, revenue benefited from better pricing in Russia and Saudi. That said, it was hurt by an unfavorable market mix, since volume fell in the high-margin Australian market, and by the prior year stock profit of roughly GBP 40 million, which had lifted revenue and profit that year. The Australian government has said there will be no 12.5% duty accelerator this year, which limits how much stock profit the industry can make this year. That adds a further GBP 50 million of headwinds to revenue and profit in the second half. We also anticipate additional market size and share declines that will weigh on profitability, though we are able to absorb these factors within our current guidance. Adjusted Operating Profit rose 8.1%. Three factors from the first half of last year have influenced our operating profit performance.

Oliver Tant

executive
#12

The U.S. wholesaler inventory pull was GBP 49 million, along with the timing of Australia's stock profit and GBP 95 million in NGP write-downs. Together, those net out to a GBP 5 million upside. During this half year, we progressed on lowering our contingent liability by reaching a settlement for U.S. state litigation in Minnesota. That's a good outcome. Settling this matter cuts Imperial's overall risk, and the somewhat higher ongoing costs remain manageable. We anticipate completing the same in Texas before long. We took a GBP 42 million charge related to the settlement. Even so, we're keeping our full-year guidance unchanged. Apart from those items, underlying tobacco performance rose GBP 76 million, or 4.8%. Underlying NGP operating income came in GBP 46 million better, helped by our more targeted investment approach and by cost cutting. Another major factor behind our year-on-year profit result was distribution, which benefited from stronger first half trading, especially in the pharma category, and from recognizing the lower inventory levels held by Logista. That comes after stock increases last year to bolster supply contingencies stemming from COVID-19. The Premium Cigar divestment diluted EPS by 3%. Organic EPS is up 6.9% at constant currency, helped by the higher Adjusted Operating Profit, partly offset by a higher tax rate, as we previously guided.

Oliver Tant

executive
#13

We anticipate the adjusted tax rate for the full year will likewise come in at approximately 23%. Generation of net cash flow continues to be robust and matches what we had anticipated. Net cash flow during the first half, though, took a hit from unfavorable working capital tied to the reversal of the temporary excise benefit seen at the close of last year, mostly because of Logista. On a 12-month rolling basis, our net cash flow rose by GBP 2.4 billion-GBP 2.5 billion. That mirrors working capital gains stemming from excise and VAT timing at Logista and in the U.K., the rebased dividend, and proceeds from the Premium Cigar divestment. Such net cash flow has been deployed to speed up deleverage, helping us move toward the lower end of our target gearing range. As a reminder, we still run a centralized cash pooling arrangement with our entities, Logista included. Although the daily cash balance will move around, across the last 12 months the average Logista benefit came to GBP 2.1 billion. Our 12-month rolling cash conversion of 122% is still elevated. As we guided previously, we anticipate full-year cash conversion of roughly 80%. That mirrors the reversal of Logista excise and duty deferment benefits that governments granted during the second half of last year. As noted, net cash flow of GBP 2.5 billion has been used to help lower our adjusted net debt, which stood at GBP 10.3 billion at the half-year.

Oliver Tant

executive
#14

On an adjusted basis, net debt to EBITDA came in at 2.6x, compared with 2.7x at the close of September and 3.5x at the end of March last year. Our focus stays on bringing leverage down toward the bottom of the 2 to 2.5x range we target. This is a solid set of results, and despite some near-term shifts in buying patterns tied to COVID, the business keeps performing well. High margins benefit the business, as does a strong record of managing cost inflation, which its pricing power further supports. We are well-positioned to fund investment in the new strategy while also strengthening the balance sheet and cutting leverage, which will underpin our investment-grade rating. The cash fundamentals of the business remain strong, supporting delivery of attractive and reliable cash returns in the future. I will now hand you back to Stefan.

Stefan Bomhard

executive
#15

Thank you, Oliver. We laid out our new strategy under four months ago. Although we are only at the beginning, implementation has already produced some encouraging early movement, and the way our people are taking to the changes pleases me. I'll walk you through that progress and say a few words about how we performed operationally, then close by summing up what matters most for the second half along with the outlook. As a reminder, three strategic pillars form the foundation of our strategy, together with three critical enablers. Some of the main actions we are taking to deliver that strategy will be updated for you today. Let me begin by describing where we are focusing and what early headway we have made on the operational levers in tobacco. There is real potential for a strong performance from the tobacco business, and my confidence in the value creation opportunities within tobacco is as clear as ever. In addition, we have kept taking meaningful steps to reset our NGP investment, concentrating on the market strongholds we already hold and getting ready for the market trials scheduled for later this year. The aim here is to build a successful NGP business that supports our commitment to harm reduction. Delivering the new strategy also requires us to alter certain aspects of how we operate, to improve our culture, and to strengthen our capabilities.

Stefan Bomhard

executive
#16

There are a few areas where we've already seen some meaningful early movement. I'll begin with combustible tobacco, since that's where sharper focus and stronger execution give us the biggest chance to create value across the coming 5 years. Looking at the tobacco market, back in January at our Capital Markets Day event we laid out detailed plans, with clear operational levers for each of the five priority markets: the U.S.A., Germany, U.K., Australia, and Spain. Those markets account for the bulk of our profit, so they'll get the highest degree of attention and backing. It's early days, but I'm encouraged that we've started to steady the combined share performance across those markets, with 6 basis points of share growth coming from three of the five. That comes after several years of steady declines and a 37 basis point drop last year. I want to emphasize that investment in the strategy has only driven this to a limited extent, since it's really just beginning. Mostly it reflects the sharper focus together with adjustments to how we manage performance, particularly aimed at those five markets. The executive team is now putting more attention in through in-depth performance review sessions with the five management teams, grounded in data and consumer insight.

Stefan Bomhard

executive
#17

What this does is build a faster, more agile company—one that can respond better as consumer requirements and market conditions shift down the road. Naturally, share is just a single yardstick for progress, and we don't really expect to deliver gains across all five markets every year. At the outset, we're concentrated on stopping the erosion, especially in places such as Germany, and on delivering steadier results over the long term. In the USA, we have kept extending the cigarette share gains we recorded recently. We got there by holding our position in the premium value segment with Winston and Kool, while our deep-discounts share kept rising through Sonoma and Montclair. That speaks to the momentum the team has built during the past year, and we intend to add further investment in line with the new strategy to capitalize on it. Hiring extra salespeople is already in progress, and we're carrying out a thorough review of sales force coverage across geographies and stores, which is shaping how those salespeople get deployed. We have likewise begun work on the new technology and sales tools needed to make our field force more effective, and we've started on longer-term brand equity efforts aimed at reviving how our focused U.S.

Stefan Bomhard

executive
#18

On the brands front, I'm eager to share more specifics with you down the road. Our mass-market cigar portfolio is a strong one, and the results we've posted are excellent, with volumes rising roughly 60% versus a comparatively soft prior-year stretch that supply shortages had hit. The fast-expanding natural leaf segment has been the main engine behind that growth. We've put money into making leaf supply more sustainable and into lifting quality, especially where natural leaf wrappers are concerned. Backwoods stands as a fine illustration of what strong execution plus a proven, well-tested engagement program can deliver, since that combination has strengthened equity and awareness among the target consumer. It demonstrates the potential this industry holds. We likewise spotted an opening in the natural leaf segment and brought out Dutch Leaf during the period, widening our presence along the price ladder. Those efforts have produced solid share gains for Backwoods and Dutch, which has helped us climb to number two in mass-market cigars, up from number four 1 year earlier. More growth opportunities lie ahead as we broaden geographic reach and connect with consumers once life events grow more common. All told, this was a very encouraging performance, and I believe we're well-positioned to grow further in the mass-market cigar segment.

Stefan Bomhard

executive
#19

The recent proposals to ban menthol cigarettes and flavored cigars will probably take several years to put into effect. We don't think the science or the evidence backs a ban, but we'll engage with the FDA in what we expect will be a lengthy process with multiple stages. Although the German and Australian markets stay highly profitable for us, we've lost market share in both during the period. In Germany, we've been losing share for the last 10 years, and our initiatives will need time before they take effect. Another encouraging sign is that the pace of decline slowed over the last six months. Our focus is on executing our market strategy, and we've started by hiring additional salespeople, since our field force is under-indexed compared with peers. This forms part of a broader effort to optimize our sales force coverage so we have the right representation across sales channels and geographies, while also strengthening our key account management capabilities. Work on the brand equities initiatives has begun, and we look forward to updating you on our progress in due course. Meanwhile, we've launched a new dual pack for Jon Player Special to meet consumer demand for different formats, and we've raised awareness through a campaign celebrating the 50th anniversary of JPS.

Stefan Bomhard

executive
#20

We feel confident that investing in the operational levers will lead to better share performance over time. My expectation is that German share will still show a decline for the full year. In Australia, we made a deliberate choice to prioritize financial delivery and implemented price increases early in the year. That had an impact on our market share. This is a market affected by downtrading, with strong growth in the 5th price tier at the bottom of the market. Parker & Simpson has grown well in this price segment, but that has been more than offset by share declines with JPS. We've launched CrushBall formats to meet shifts in consumer demand, and our Riverstone brand has grown share in the fine cut segment. Work is underway on our operational lever, but as with Germany, it will take time for these to take effect. We achieved better share performance in the U.K. and Spain, both of which have been supported by a focus on local jewel brands. This is an important strategic change, where we are now focusing on these local brands, which have been neglected in recent years in favor of their international counterparts, contributing to our share losses. In the U.K., we're focused on Embassy with the launch of Embassy Signature, coupled with an approach to fill regional gaps in brand presence.

Stefan Bomhard

executive
#21

We've been able to do this by making use of the trade incentive programs we already have in place, which have earned independent recognition as best in class. In Spain, gains across several brands in the portfolio have helped support our share, including Nobel and Fortuna, where we're starting to tap into their potential. Nobel holds strong equity in Spain with national coverage, and we've capitalized on that through a successful limited edition pack program during the past year, featuring artwork commissioned from a well-known local artist. With Fortuna, we've also put money into new pack formats, and those have done well. Under the new strategy, we're going to keep increasing our investments in these operational levers so we can strengthen our tobacco performance and build on this early good progress. Moving on to NGP, I think we have a significant opportunity to build a successful NGP business over time — one that leverages our strengths and focuses on meeting consumer needs. Our approach will be more measured and disciplined, and that shouldn't be read as any lack of conviction in NGP. It's quite the opposite. I wanted to build a business that does a better job of attracting adult smokers and is therefore successful, so that Imperial can contribute meaningfully to harm reduction.

Stefan Bomhard

executive
#22

We have thoroughly evaluated where we stand in the market, what opportunities exist in the category, and how effective our investment has been, and that has led us to target our investments better behind our strongholds in the U.S. and Europe. During our strategy update in January, we laid out the way we would prioritize investments across certain category market combinations. In vapor, we have concentrated our investments even more narrowly, consistent with our strategy, on the U.S. and key European markets, where a strong market position has already been established by leveraging our route-to-market. Our investment has been more targeted in marketing and point-of-sales activities with a proven track record, which lets us retain strong positions in markets such as Germany and Spain. In markets like the U.S., we have also decided against taking part in some of the more aggressive discounting that is common in the sector, which has caused some share pressure. Another notable change in how we operate is our greater emphasis on performance management and collaboration to drive improved results. This disciplined approach, along with our negotiations for better trade terms with retailers, has significantly reduced losses, even leading to some markets becoming profitable on a local basis. There are some markets where the business case is hard to justify, so we have chosen to withdraw from several markets, such as Japan and Russia, where we lacked the route-to-market scale to make it work.

Stefan Bomhard

executive
#23

What we're doing here is resetting so that we have a solid foundation on which to rebuild a better business. A revised consumer proposition for blu is in the works. Too often, our emphasis has been on the product and its features, and there's room to do better on brand building and on how we connect with our target consumers. That's a top priority for Anindya Dasgupta, who came on board recently in the newly created Chief Consumer Officer role. Our plans remain on track to test these new propositions with consumers in a targeted geographic area in the U.S. later this year, all within the U.S. PMTA rules. When it comes to heated tobacco, we have a clear plan to give consumers greater choice in selected European markets where the category is well established and where our existing route to market and local insight can be leveraged. Because of that, we've decided to exit from Japan, where we lacked the scale to make a success with Pulze. Still, some useful insights have come out of this extended trial. I'm pleased with the progress we're making towards launching the pilot trials of a revised consumer proposition in two European markets later this year. This work is already benefiting from the insight and involvement of Andy, who began getting engaged in this work over the last couple of months, even ahead of joining us.

Stefan Bomhard

executive
#24

The markets we selected already show solid penetration and familiarity with the heated category among adult smokers. Once the trials get going, I'll be glad to share further specifics. When it comes to modern oral, we're concentrating on Scandinavia along with select European markets that have a track record with oral nicotine products. Demand in modern oral is climbing quickly, especially across Scandinavia. Our volumes overall are 50% higher versus last year, powered by robust growth in Norway and Austria. With consumer demand rising in that category, we've got new product launches lined up for the second half. To sum up, we're still in the early stages of the journey for our new NGP's. Progress on resetting our investment has been good, and I look forward to bringing you updates as the trials proceed later this year. Three critical enablers underpin our new strategy: placing the consumer at the center of the business, embedding a performance-based culture and capabilities, and making sure our operations are simplified and efficient. After spending time with our people and watching past behaviors and processes, I'm more convinced than ever that driving change here is truly critical to executing our five-year plan successfully.

Stefan Bomhard

executive
#25

A major shift involves putting the consumer at the heart of the company and making sure every important choice we make rests on consumer data and insights. At the executive level, the consumer's voice had been absent for 4 years. As I noted, I'm very pleased that Anindya Dasgupta came on board at the start of May as Chief Consumer Officer. Andy will drive our consumer focus by making certain we possess the proper marketing, brand, and portfolio management capabilities to back both our tobacco and NGP businesses. He'll additionally supervise the company's effort to bring a much more joined-up approach to the way we gather and utilize consumer insights and data. Anindya carries deep experience in those areas, having served in senior positions at major global consumer goods companies including PepsiCo, Fonterra, and GSK. Anindya will be responsible for a freshly defined Innovation Program, ensuring we maintain a pipeline of both combustible and NGP products. Everything will be dictated by the consumer, who will sit at the center of our culture. How we operate and how we'll deliver our strategy depends critically on culture. Our aim is a performance-based culture built around teamwork, collaboration, and accountability.

Stefan Bomhard

executive
#26

We have already implemented two significant adjustments to the incentives framework aimed at strengthening these behaviors. The first involves establishing stronger alignment with group objectives, meaning that 80% of the annual bonus now hinges on group metrics. That matters for fostering integration and eliminating silos. The second adjustment concerns altering the market share metrics used for the bonus into a weighted average across five priority markets. Doing so will guarantee that we expand share in those markets responsible for driving profit and value. In addition, we are revising our LTIP metrics to support delivery of sustainable earnings growth, a robust balance sheet, enhanced returns on capital, and total shareholder return. I keep urging employees to share feedback openly. During this year, we have adopted technology and carried on holding town halls while visiting manufacturing sites, though doing so virtually. Over the coming few months we will build on these efforts through an employee engagement roadshow, collaborating with our people around our new purpose, vision, and values. We are making our ways of working simpler, and our early emphasis has centered on customer and consumer-facing areas. We recently disclosed plans to streamline our sales and marketing organization by cutting the count of market clusters from 13 down to 10. Every one of our markets will receive an organizational structure customized to its strategic role, one that distributes resources consistent with how we prioritize markets.

Stefan Bomhard

executive
#27

That way, every market will have the consumer insights and capabilities it needs to deliver against its plan. We have also reinforced cluster leadership via a number of key appointments. Within NGP, operations are now unified under our new Chief Consumer Officer, with a clear category-led structure that aligns with the new strategy, including new heads for each category area: vapor, heated, and modern oral. In other areas, design work is moving forward on the enabling functions, so that resource and service are allocated efficiently. These represent the first steps toward transforming the business and unlocking value for our stakeholders. In conclusion, I believe the year has gotten off to a good start. A tighter focus on performance management in our priority markets is helping drive stronger operational and financial performance. In the second half, we will begin to step up investments behind the strategy, in line with our plans. Despite this, our full year guidance is unchanged, with low to middle-single-digits Adjusted Operating Profit growth at constant currency, excluding the impact of the Premium Cigar sale. Let me walk you through some details on the moving parts. Clearly, COVID-19 continues to impose restrictions across our markets, affecting travel and consumer buying patterns.

Stefan Bomhard

executive
#28

We think those restrictions will ease, though the duty-free channel is probably going to stay significantly depressed for the remainder of the year. In a similar way, we've seen the benefit of improved volumes in some markets because of border closures. We expect a gradual return to more normal rates of decline over time. Tobacco revenue in the second half should be affected by mixed headwinds, since some of last year's COVID-related benefits unwind during the second half. For example, the U.K. stock profit and the German VAT benefit. As Oliver mentioned, there will also be a headwind of around GBP 50 million from lower stock profit in Australia. Despite these headwinds and increased investments behind our strategy, second half tobacco profitability is expected to grow modestly against the same period last year. Our disciplined approach to NGP will support investments behind the new market trials in heated tobacco and vapor while maintaining investment levels and therefore losses at a similar level to the first half. As previously guided, a higher tax rate will have a circa 2% impact on earnings, with organic adjusted earnings per share expected to be slightly ahead of the prior year at constant currency. Adverse foreign exchange translation is expected to be a headwind of almost 3% on full year earnings.

Stefan Bomhard

executive
#29

As you can imagine, our agenda is packed, and we remain relentlessly focused on embedding the new strategy we launched in the first half of the year. In our priority tobacco markets, we're keeping up rigorous performance management and will put investment into our key operational levers. In NGP, we intend to start trial market launches of our new customer propositions in both vapor and heated tobacco. We'll roll out the new organizational design for sales and marketing and keep adopting new working practices. Our emphasis on strong cash flow will stay a key priority. From a capital allocation standpoint, we're clearly on the path to deleverage and to strengthen the balance sheet. That will also let us deliver enhanced cash returns to shareholders, which we fully recognize as an important part of the investment proposition. We've made a good start, and I'm excited about the future and truly believe that over time we will deliver stronger and more consistent performance and unlock long-term value for shareholders. Thank you for joining us today and for giving us the opportunity to take you through our results. We'd now like to take your questions.

Stefan Bomhard

executive
#30

I'll give the floor back to the operator so we can begin the Q&A. Thanks for tuning in.

Operator

operator
#31

Thanks. Just a quick reminder that to ask a question, you'll need to press star one on your phone. If you'd like to withdraw your question, press the pound hash key, and please hold while we put together the Q&A roster. Today's first question is from Gaurav Jain at Barclays. Go ahead, your line is open.

Gaurav Jain

analyst
#32

Hello, and good morning. Thanks, Stefan and Oliver. There are three things I'd like to ask about. First, on leverage: it's clear you got a boost in 1H from foreign exchange of nearly GBP 700 million, which appears on Slide 15. Your leverage is landing below what we had anticipated. What does that mean for your thinking on the timing of share repurchases? And how do the rating agencies view your leverage at present?

Stefan Bomhard

executive
#33

Okay, Gaurav, morning. Stefan here. First off, we're happy with how deleverage is coming along — that's clear progress — but I'll hand things to Oliver so he can take you through the specifics.

Oliver Tant

executive
#34

Thanks, Gaurav. You're correct in saying that we're clearly quite happy with how deleveraging has gone during the first half. Still, I think we ought to keep in mind that a portion of that came as a benefit from what has occurred on the currency side. Of the roughly GBP 700 million effect on our net debt balance, 25% stems from sterling's strengthening and the consequences that has had for the value of that debt. The underlying level, naturally, has also gained in terms of cash generation levels from the proceeds arising from the divestment of our Premium Cigar business, which helped the period too. When we look at underlying momentum, it aligns very closely with the path we laid out and discussed at the Capital Markets Day earlier this year. I think that, as a group of analysts, you should take comfort from the fact that we are delivering entirely in line with our expectations. Our expectation regarding when we reach the point at which we achieve our target matches where we stood earlier in the year.

Stefan Bomhard

executive
#35

I'd say the key thing is just to underline what Oliver mentioned last: we ought to be seeing that half year of deleverage now being delivered, the one we discussed at the Capital Markets Day.

Gaurav Jain

analyst
#36

Of course — thanks. My next question concerns Pulze and the launch set for later this year. We're currently seeing patent litigation among certain companies in the sector involving heat-not-burn technology and products. In what way are you thinking about those kinds of issues, and if they arise, how would you deal with them at the time you launch Pulze?

Stefan Bomhard

executive
#37

Right. One point worth noting, and it's important to understand, is that the basic version of our Pulze product has been available in the Japanese market for quite a while now, and it hasn't faced any litigation challenges there. Yeah. That gives us some confidence that, to the best of our knowledge, any litigation on this front shouldn't affect our launch in Europe.

Gaurav Jain

analyst
#38

Alright, regarding heat-not-burn: right now there’s a tax gap between cigarettes and heat-not-burn products in every part of the world, Europe included, and in a market such as the U.K., which you really aren’t making a priority for your heat-not-burn launch. Someone could make the case that this tax difference actually hurts your cigarette business. Do you believe the tax gaps are too wide in some markets and ought to be narrowed?

Stefan Bomhard

executive
#39

Apologies, Gaurav. I was working through what you were asking. The question concerns how appealing a few markets are for heated tobacco, is that right?

Gaurav Jain

analyst
#40

What I’m trying to get at is this: in certain markets such as the U.K., the tax difference between heat-not-burn products and cigarettes actually works against you if consumers continue shifting toward heat-not-burn products in the U.K., where you don’t have a presence. Would you be making the case for closing those tax gaps over the long term?

Stefan Bomhard

executive
#41

Alright, understood — sorry about that. The way things actually are, I'd say one element of it is that our overall NGP strategy, like everyone else in the industry's, rests on the expectation that governments worldwide will use their tax systems to give consumers an incentive to move to NGP products. Yeah. I'd say the strategy has a certain robustness to it, in that it doesn't hinge on a government landing on one precise position. To be clear, I do expect continued shifts in tax rates on NGP products in different countries over the coming years. Yeah. On the whole, the direction we're observing matches our expectations. Yeah. Back in January, when we put our strategic plan together, yeah, we anticipated that taxes on NGP products would go up. Nothing we've seen over the past couple of months gives us any concern on that front.

Gaurav Jain

analyst
#42

Alright, thank you very much.

Operator

operator
#43

Thanks. Adam Spielman from Citi is our next caller with a question. The line is yours — go right ahead.

Adam Spielman

analyst
#44

Thanks. I have three quick questions. Let me go back to share buybacks — could you simplify it for us? When is it reasonable for us to expect share buybacks? And has there been any added pressure from the rating agencies tied to the chance of a multiple ban in the U.S.? That is my first question.

Stefan Bomhard

executive
#45

I'll take that, and Oliver will come in with further detail. Broadly speaking, in today's capital markets, I believe we've laid out quite clearly what our policy on capital allocation is. What you ought to take from today's results is that we are delivering on the deleverage we committed to at this point. In Oliver's reply to Gaurav, one thing I'd simply ask you to keep in mind is that there can always be moving pieces around this. So for that reason, we don't want to provide a forecast of when we will reach that targeted deleverage level. I'd ask for your understanding on that. On your second question about the rating agencies, to be clear, we are in ongoing dialogue with the rating agencies. The strategy we've set out is very much aligned with the discussions we've held with them in order to protect our credit rating in this context.

Oliver Tant

executive
#46

Regarding pressure, Adam, what you'll notice is that each of the three rating agencies now carries a Stable outlook. In fact, we've bettered that situation during the last few months or so, when we had been placed on negative watch — due, I believe, in part to uncertainty regarding what lay ahead for us, with a new chief executive coming in along with a new strategy. Their ratings have now taken account of that, and all three agencies that previously reviewed us have us at stable outlook.

Adam Spielman

analyst
#47

Alright, my second question concerns innovation and Next Generation Products. I see that you emphasize a lot the need to connect with consumers on a more emotional level, yet product upgrades aren't mentioned anywhere. I'm quite aware that PM and JT and BAT, and Juul as well, are putting in a great deal of money — hundreds of millions of GBP — into improving their products. So I'm just wondering: in this category, do you genuinely think an emotional connection is sufficient? Because when I look at it, I feel your products simply have to be substantially better, and that is going to cost a lot.

Stefan Bomhard

executive
#48

Sure. I think that's exactly right. Let me clarify — this isn't only about an emotional connection. As someone trained as a marketer, I see it as bringing together what you offer as a product, your marketing program, and that emotional link. And to be clear, it also covers route-to-market: where can my consumers actually buy my product, and at what price? It's the full marketing mix. What we were trying to emphasize, I think, is that in the past we leaned very heavily on our product offering to carry our message. Now that Andy has arrived and we genuinely have a marketer sitting on Imperial's top team, we want to raise the bar on the quality of marketing communication with our consumers. To be clear, product and product innovation will keep playing a significant role. The second thing I'd like to note here — and I think this matters — is that as the number four player globally, we are not aiming to become the market leader in NGP. Our strategy today is squarely focused on NGP countries that have a sizable NGP segment, where consumers are increasingly seeking choices. In principle, our assessment is that in these markets, with what we have to offer, we can compete for the market share we're targeting as part of our strategic plan.

Stefan Bomhard

executive
#49

Just so we’re clear, one element of our market tests—the trials we have planned for NGP, specifically our vaping product here in the U.S. and now two European heated tobacco markets—is to validate our proposition.

Adam Spielman

analyst
#50

All right. Lastly, I’d like to discuss your tobacco brand strategy, which appears to center heavily on local heritage brands. Given what has happened in tobacco over the last 20 years, that approach is quite unusual. All the growth has occurred in international brands, and the shift has been entirely toward them. Of course, you do have some strong local heritage brands, but do you believe you can keep going that way? Is this essentially a permanent strategy — now that everyone else is moving toward international brands and concentrating on them more and more, you will be more or less the only company focused on local heritage brands? Is that how you expect things to unfold for many years ahead?

Stefan Bomhard

executive
#51

Yes, thanks for asking that, since it gives me a chance to clear up something: this is about combining attention on global brands with attention on local brands. The distinction is that we therefore aren't pursuing a plan centered only on local brands. Here's the strategic shift: over the past couple of years we had entirely overlooked local brands. Investment in our local jewel brands had been minimal. For instance, they were shut out of any innovation-related backing and of significant marketing expenditure. In our view, that was an error. If you truly put the consumer at the center, then given our company's history, we hold a disproportionately large share of strong local jewel brands thanks to the acquisitions we've made. That's what the strategy has put right. Rather than allocating nothing to them and pushing to move them into global brands as quickly as possible, we place the consumer first, saying our global brands remain priority number one, absolutely. We are now adding to that with chosen bets on local jewel brands. As you can see in this set of results, if I may point it out, in the market share figures, 2 of our top 5 markets have gained share in the U.K.

Stefan Bomhard

executive
#52

And Spain. A really big chunk of that share gain has come from putting money back into local brands — in Spain, in Nobel and in Fortuna, and in the U.K. into the launch of Embassy. In fact, in this set of results we can see the first green shoots of beginning to reinvest in some selected local brands. That doesn't mean we won't invest in our global brands. It's a combination of the two.

Adam Spielman

analyst
#53

All right, thanks so much — that wraps up my final question.

Stefan Bomhard

executive
#54

Thanks, Adam.

Operator

operator
#55

Thanks. The next question is from Alicia Forry at Investec. Go ahead, your line is open.

Alicia Forry

analyst
#56

Oh, hello there. Good morning, everybody. Appreciate the questions. There are two of them. The first concerns Australia, which, I suppose, has had a harder time turning around as fast as certain other markets did, for the reasons that you pointed out. What I want to ask is whether you believe the pricing architecture you have for that market is the right one over the longer term. Second, regarding the U.S., could you elaborate a little on what makes you confident about a U.S. vapor turnaround, given that competitors have clearly made a big push there over recent months? I would just welcome a bit more detail on how you figure you can win back some of that share you have lost. Thank you.

Stefan Bomhard

executive
#57

Yes. Those are two excellent questions. Regarding the pricing architecture in Australia, I'm confident that our product lineup and pricing structure allow us to compete effectively there. Let me clarify that further. The share loss reported in the half year results for Australia stems mainly from our choice to raise prices and pass duty excise through to consumers and customers. But some of our competitors decided not to follow suit, and particularly at the lowest entry, the fixed price tier of the market, we became uncompetitive. Every bit of our share loss ties back to that particular price tier. Over the last couple of months, we've taken corrective steps. We began recovering that share very quickly. I feel quite confident that nothing problematic from a consumer standpoint sits behind our brand architecture or pricing architecture. It was a very clear choice that hopefully will fill you with confidence that we're not here buying our shares. We're actually here, we're pricing wars on our competitors at the beginning of this fiscal year. That hopefully gives you some confidence. We have the right product hierarchy, we have the right pricing architecture to actually compete in the Australian marketplace.

Stefan Bomhard

executive
#58

On your second question regarding the U.S., with NGP and blu in particular, we're going to run a market test there, in one region of the country, where the entire proposition gets tested. That's mainly about resetting how we do marketing and how we go to market. We genuinely think that once those two key marketing elements are reset, there's absolutely an opportunity for us to compete in the U.S. market. Let me go back to one earlier point. In the U.S. market we're the number four or number three player — four in NGP, three in tobacco, depending on how you look at it. To make money in this marketplace, our ambition doesn't need to be number one and number two. That's an important thing to keep in mind when you consider our ambition. It ties back to the question of what the right ambition is for this company. My final point on NGP is that some of the market share movements, if you look very closely, come from very heavy device discounting down to $0.99. You have to ask yourself — I believe you'll get decent initial trial. I think you'll find out whether consumers stay with your brands once pricing moves up, and what kind of loyalty deep discounting of devices actually buys you, which is a technique we at Imperial have not used and have deliberately accepted some market share loss over, because we're not sure that's good market share.

Alicia Forry

analyst
#59

Thanks.

Operator

operator
#60

Thanks. The following question is from Patrick Folan with Redburn. Please go ahead.

Patrick Folan

analyst
#61

Hello there, and good morning. I have a couple of questions, if I may. The first one concerns Germany — I was hoping you could give us some more detail on what's going on from a portfolio standpoint that's driving the headwinds we're seeing right now. Is it more a matter of branding focus, or is it the portfolio that needs shifting toward value formats? And has there been any improvement in East Germany, where prices are somewhat more competitive, or does that really hinge on the sales improvement you have underway?

Stefan Bomhard

executive
#62

Yes. Patrick, good morning. We're quite pleased with your question. When you examine it, one point stands out: we continue to lose share in Germany quite clearly, though the share loss is smaller than it was last year. For 10 years in a row now, we have lost share in Germany. What I view as an encouraging signal is that the rate of decline is slowing. It's very clear that's not where we want to be midterm. At least it shows some first green shoots that the initial actions are beginning to deliver some benefit. Just a specific part of your question. What we are seeing is that our sales efforts are starting to begin to make a difference, but we're at the relatively early stages here. Yeah. Our brand renovations, reinvestment in brand equity in JPS and in West and in Gold Leaf are at the early stages. The arrival of Anindya Dasgupta, who's now deeply involved reviewing the marketing programs, will only start to make a difference over time. To the question of East Germany, where we historically hold a lower share than in our national market. One thing that has hurt us, with the border closures towards the Czech Republic and Poland because of COVID-19, the East German market has actually become more important, therefore it actually has a negative impact on our overall market share, because suddenly East Germany is a higher weighting of the total German share, because consumers do not travel into Poland and Czech Republic at this point in time.

Stefan Bomhard

executive
#63

So there, the main thing is reorganizing our sales force. We're working on better coverage of outlets in East Germany, though that's still in progress. To sum up, you can see the very early signs of our new strategy being put in place in Germany, but it's probably the place where we'll take the longest. When I look at it, the steps we've taken, they are starting to show the results we're looking for, but there's a lot more to come, especially on the brand side.

Patrick Folan

analyst
#64

Sure, that’s clear. One thing on the Dutch Menthol Leaf brand extension you mentioned: given where menthol stands right now, does that still make sense? Are the cigars leaning more toward straight tobacco taste rather than flavor profiles that might face a ban?

Stefan Bomhard

executive
#65

Absolutely. Great question. The main reason behind this — and I'm glad you asked — is that, if you take a look, for a very long stretch we've held a strong position in the mass-market cigar segment through Backwoods. It's quite evident that Backwoods carries a very premium price, sitting at twice what the market typically charges. Our consumer insights are solid. As we laid out at the capital markets today, we genuinely view mass-market cigars as a highly attractive segment. It's a segment that's growing in the U.S., yet we've only competed at the premium end. What we've decided is to truly meet all our consumers' needs by placing a new product offering under the Dutch brand name at a lower price point. It addresses a consumer need that we at Imperial haven't met before, and the early success, given the quality we're able to deliver, has been very strong with consumers. We haven't really tied it to any possible bans on flavored cigars. It's simply us entering a price segment where Imperial hasn't really competed, and the initial response has been quite strong.

Patrick Folan

analyst
#66

Alright, thanks.

Operator

operator
#67

Thanks. Just a quick reminder — if you want to ask something, hit star and one. Our next question is from Sanath Sudarsan at Morgan Stanley. Go ahead. Your line is open.

Sanath Sudarsan

analyst
#68

Good morning, Stefan, Oliver, and the team. I have two questions, if I may. First, you mentioned share gains in combustible products across your 3 strategic markets — the U.S., the U.K., and Spain. Could you give us a clearer picture of how you're performing in those markets relative to the overall nicotine user base, just so we can gauge how the NGP movements are playing out in these key markets? Second, Stefan, you've stated your intentions several times today regarding meaningful harm reduction. Could I push you a little on what counts as meaningful in your view? Thank you.

Stefan Bomhard

executive
#69

Absolutely. Regarding total nicotine market shares, I'm glad to walk through the top markets. The straightforward ones are easy. Take Spain, for instance: the NGP segment there is comparatively small, and in fact we hold the number one share in vaping, which is the biggest category in that market. Honestly, I feel quite encouraged when I look at total nicotine share, since it's worth remembering that we were losing share in Spain over a lengthy stretch. The renewed emphasis on Nobel and Fortuna as local jewels, alongside global brands such as West and JPS, is genuinely pushing share ahead. Very pleased with that. Moving to Germany, the reality there is that we're maintaining our share in the NGP segment behind blu in a very solid manner, and I think we'll have to watch how things develop on the nicotine side given the legislation in that area. Right. Broadly, the difficulty in total nicotine in Germany is plainly on the tobacco side. Right. Turning to the U.S., the reality is, as you're aware, when you examine it, the NGP share of overall nicotine consumption is simply advancing the way it would have previously, and so our U.S. priority of capturing more of our fair share in vaping is the central item we're focused on.

Stefan Bomhard

executive
#70

I believe that what we're doing under our new strategy to reach the right share position in the U.S. is absolutely right, since we're now beginning to grow faster on our tobacco share, and at the same time, through the market trial, we're addressing how do we compete in the vaping segment? Yeah. To round it off, U.K., you've seen a very strong performance. Also, our vaping proposition is doing quite well. The heated tobacco segment tends to be quite small at this point in time. I think also happy about our total nicotine proposition there. I'm just trying, Australia, as you will know, there is no legal NGP offer. We're really talking about the tobacco position there. Yeah. Hopefully, that gives you an idea where we're there. Thank you. Can you just remind me of the second question, please?

Sanath Sudarsan

analyst
#71

No, absolutely. What I'm trying to get at is how you define meaningful harm reduction. What does "meaningful" actually amount to in numbers?

Stefan Bomhard

executive
#72

I think, to be clear, it would probably be better placed once these market tests have completed. I think what you should definitely read into it, we do believe we as one of the large players in our industry, we wanted to make the right contribution and offering our consumers a harm-reduced product offering. I wouldn't want to put a number at this point in time because we're talking about a market that is still highly volatile, still in development, but it will make a meaningful difference to the harm reduction for our consumers. It will also, over time, hopefully make a meaningful difference to our financial situation as a company.

Sanath Sudarsan

analyst
#73

Thanks.

Operator

operator
#74

Thanks. The next question is from Jon Leinster at Societe Generale. Go ahead, your line is open.

Jon Leinster

analyst
#75

Thanks, and good morning. I have three if I may. The first is just about the sales force expansion in the U.S. and Germany: has that already begun within the U.S., and will it really be arriving in the second half of this year and therefore ought to begin having an impact next year? Could you perhaps provide a timeline for when you expect the results of that expansion, please?

Stefan Bomhard

executive
#76

Sure thing, John. Morning. Exactly. Basically, what's taken place is that during half 1, we've mostly done the prep work. We've brought people on board, but as you're aware, if you're going to hire folks properly, they're in the middle of training at the moment. Practically speaking, these new team members are going to be out meeting customers during the half two in the U.S. and in Germany. The reality is that when they pursue new territory, we shouldn't lose sight of the fact that these are customers we haven't been reaching through face-to-face interactions. From a financial standpoint, to frame it that way, the net revenue effect in the second half is going to be on the smaller side, but the second half will carry an investment element since our new colleagues' salaries sit within it. You're going to observe the payoff from a market share standpoint, most likely more so in fiscal year 2022, once they've discovered the right routes, established relationships with the customers, and put the correct picture of success and shelfing out there. That's the way I'd see you being able to monitor the progress we're going to make.

Jon Leinster

analyst
#77

Alright, thanks. On to the second question — perhaps I heard you wrong. Was it 60%, six, zero, that you said U.S. mass-market cigars rose?

Stefan Bomhard

executive
#78

No, you heard correctly. It really is up 61%. Yeah. Okay, before we get too excited, John, let me just help you put that in context. First, the major brand involved here is Backwoods. During the first half of 2020 — the like-for-like comparison period — Backwoods ran into supply chain problems, since we're very focused on ensuring the leaf quality is right. Yeah, we've seen such a jump. In fact, supply was a real struggle for us last year. Logically, the plus 61 was aided by the fact that the base was quite low. To be clear, it was also aided by the Dutch launch we mentioned in one of the earlier questions, where you get that pipeline filling effect as well, plus our retail partners giving us additional shelf space and stocking the brand. Yeah. Please don't expect that to repeat in half two. We'll still post a positive number, but I think you should probably look at the bigger picture: there's a segment that is actually growing overall, in volume too. We at Imperial hold the strongest brand in that segment. We're building out our portfolio. And we're reaching a supply chain situation that over time will actually let us meet consumer demand.

Stefan Bomhard

executive
#79

For years ahead, this ought to serve as a growth engine for our U.S. business, and it's plainly built into the global strategy we have overall.

Jon Leinster

analyst
#80

Sorry about that. I was actually going to ask this: with growth at that level, do you really have the capacity to keep up that kind of substantial growth rate you’ve been seeing, or is that something where you’d need to invest a good deal more to sustain that kind of growth?

Stefan Bomhard

executive
#81

The investments are in place. Just to clarify, leaf supply comes from independent farmers, so that isn’t a capital expenditure item on Imperial’s side. As for manufacturing capabilities, we certainly have those, yes. We’ll be in a position to grow these brands in line with our forecast. One caveat: please don’t anticipate 61% year-on-year growth. That’s the main point. What you should expect is solid, positive growth—ideally, as time goes on, double-digit growth as well, supported by the brand proposition here.

Jon Leinster

analyst
#82

Thank you. And finally, it's clear you reached a settlement involving Minnesota and Texas. Does that cover every remaining disagreement with U.S. states, or might additional ones still arise related to that provision for the MSA disputes?

Oliver Tant

executive
#83

My answer would be that it only applies to Texas and Minnesota. There is ongoing litigation with Florida, but our position there is one we feel very strongly about, and that's the reason you won't find any provision reflected in how we stand regarding that case. It isn't comprehensive, yet it addresses the areas we judged reasonable to resolve given where our position currently sits.

Jon Leinster

analyst
#84

Alright, thanks a lot.

Operator

operator
#85

Thanks. There’s one more question, and it’s from Faham Baig at Credit Suisse on the line. Please go ahead — your line is open.

Faham Baig

analyst
#86

Good morning, everyone. I’ll follow the pattern and ask three as well, please. Could I begin briefly with the mass-market cigars business? Stefan, you said it is growing in volume. What do you believe is behind that result? What would help? Just on that point, has there been a price increase? I understand one of your competitors announced a price increase at the start of the year. Have you raised prices there as well? That is my first question.

Stefan Bomhard

executive
#87

Sure, happy to take that. Good morning. First, why is mass-market cigar growing? There are two things behind it. The main one is that we've picked up market share. Yes, we've taken a very substantial share of that category. Yeah, that's the primary factor. A lesser factor is that, if you look at overall nicotine consumption in the U.S., this is really the one segment that's growing at a healthy pace, as consumers shift toward this kind of product offering in the market. Yeah. On the matter of price increases, with Backwoods we're the most premium-priced product out there. We sit at double the price of the next competitor. In fact, we haven't implemented any specific pricing on this. Yeah, pricing hasn't been a major driver in an outsized way when it comes to the 61% growth.

Faham Baig

analyst
#88

All right, great. Turning now to modern oral nicotine pouches: can you remind us of the current size of that business for you? And could you perhaps walk us through the strategy in modern oral specifically? I know you said there are some market trials in the other two NGP businesses, but what's the approach here, and what might cause you to potentially reconsider your stance on bringing oral nicotine into the U.S., where you'd have a very strong route to market, and then obviously there's a possible return benefit in that market as well? Thank you.

Stefan Bomhard

executive
#89

To give you a sense of scale, our modern oral nicotine operation is approximately a GBP 15 million business. That's just to provide some perspective. It matters, but clearly the EVP side makes it look small by comparison. Now, let me be clear — asking about the U.S. is entirely fair, though I'd suggest we take a broader view. In our European markets we hold a very strong position, since the brands there are well-established and consumers have formed a habit around them. You're quite right that the one market with a well-established oral nicotine segment where we have no presence is the U.S. Yes, that's absolutely correct. As you'll be well aware, launching a new brand in the U.S. means going through a very lengthy PMTA process, unless you acquire a competitor there — something we've decided against. I think there are bigger opportunities available to us as a company. We'll watch how things develop over time. As for that GBP 15 million, we believe there's a larger opportunity for Imperial to compete in the far bigger vaping sector.

Faham Baig

analyst
#90

Alright, one last question. I believe you also noted on the slide deck that your share across the top five markets rose 6 basis points, yet your overall tobacco share actually gained 30 basis points. Which markets are creating that gap? Is it your own execution driving that result, or is it a matter of product portfolio? It would be helpful to understand which specific markets are behind that.

Stefan Bomhard

executive
#91

A major factor is that our five largest markets cost us 37 basis points exactly 12 months ago. The real biggest gain, though, comes from our core markets. When you ask why the broader markets continue to post stronger share gains, a few of them are large-volume markets, since we're discussing volume share. You're talking about markets such as Saudi Arabia. You're talking about markets such as Russia within our portfolio. A few markets where we genuinely deliver solid market share performance. Going back to strategy, these aren't markets where Imperial, as a company, earns a lot of money. That's one element, but I think what's probably reassuring for you is that the focus on the top five markets hasn't held back some of the other markets in terms of our market share position. And just to complete the picture on this one, our African markets, which we flagged as a strategic priority, also delivered some very strong share performance — probably, of all of them, the most important, because strategically they sit outside the top five yet not too far behind, which gives us confidence in our strategy over the longer term.

Faham Baig

analyst
#92

No, thank you.

Stefan Bomhard

executive
#93

Yes.

Operator

operator
#94

Thanks, and our next question is from Jonathan Leinster at Societe Generale. Your line is open, so please go ahead.

Jon Leinster

analyst
#95

Hello again, everyone. My apologies for that.

Stefan Bomhard

executive
#96

That’s not a problem at all.

Jon Leinster

analyst
#97

Only a quick question. You said the total market size for the first six months was down 3.2%, and obviously that's partly with COVID sort of unwinding. For the full year, what would you expect the market size to be down, please?

Stefan Bomhard

executive
#98

It's a difficult one, honestly. I wanted to lay out the dilemma for you. Looking at it, the total market size has gotten a modest boost from COVID. As COVID begins to ease, I believe we'll see volume market declines come back more toward historical levels. The challenge everyone faces right now — with our second half running April through September — is that forecasting how much unwinding will happen over the coming couple of months is really hard at this point, mainly, to be fair, because of travel restrictions. It comes down to whether consumers can get back to their usual consumption habits. If you asked me right now, I'd tell you there will be a gradual return to normal consumption patterns, and therefore to normal rates of market decline on a volume basis. What I don't expect is a full return to a normal pattern within the second half.

Jon Leinster

analyst
#99

Great. All right. Thanks a lot.

Operator

operator
#100

Thanks. The next question is from Jared Dinges at JP Morgan, calling in. Go ahead — your line is open.

Jared Dinges

analyst
#101

Hey, everyone. Honestly, everything I wanted to ask has already been covered, though perhaps there's just one short item. Over in the U.S., for some time now, we've noticed a bit of downtrading moving from the premium discount segment into the deep discount segment. Do you expect that to keep going? Are you making adjustments for it and shaping your strategy around it? Maybe you could say a word about that.

Stefan Bomhard

executive
#102

I think one aspect of becoming more consumer-centric as a company is that it matters to us to follow our consumers and to want to serve them wherever they happen to be. I think one of the exciting things for us at Imperial is that, while we are only the number three player in the U.S., we do have an attractive offer in the deep discount segment. Yeah. One thing I think sets us apart in the U.S. is that, of all the big players, we are the one with the most complete assortment of brands, going from premium all the way down to deep discounts. Yeah. The ability to serve our consumers — and you're right, if there is a segment that has grown over the last couple of years, slightly ahead of the rest of the market, it is that deep discount segment. Yeah. Which we do serve as well as a brand, and it has helped us on our share development. Yeah. That is something I'm very happy with. When we look at now with Andy arriving as a new Chief Consumer Officer, we're looking at what offer, what brand offer we have for what price point in the U.S. market. Yeah. You will be aware that the deep discount segment in the U.S., despite its name, is still a very attractive segment for industry players like ourselves from a gross-margin perspective.

Jared Dinges

analyst
#103

Appreciate it.

Operator

operator
#104

Thanks. At this point I'll turn the call back over for closing remarks.

Stefan Bomhard

executive
#105

All right, absolutely. To start, I appreciate the excellent set of questions. I hope this gives you a solid picture of what has been a strong beginning to the year. We're really pleased with the top-line performance, particularly our ability to hold market share steady across our top five markets. We're expecting a good year ahead, though it's nice to have the first half behind us, and I'd simply like to restate the guidance we provided for the full year. I hope we'll be able to see you in person when we report the full year results. None of us is abandoning hope on that front. Okay. Take care.

Operator

operator
#106

Thanks. That brings us to the end of today's conference call. We appreciate everyone joining us. You're free to disconnect at this point.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Imperial Brands PLC transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Imperial Brands PLC earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Imperial Brands PLC or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.